Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-inflammatory compounds and uses thereof

A technology for compounds and drugs, applied in phosphorus organic compounds, applications, anti-inflammatory agents, etc., can solve problems such as non-conformance and limited sequences

Active Publication Date: 2013-05-15
巴赛尔·雷盖斯
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, conventional NSAIDs clearly do not meet two important criteria for their widespread use as chemopreventive agents against cancer, namely, safety and high efficacy, since NSAIDs are associated with a large number of side effects and their sequences are rather limited, no more than 50% ( Rayyan Y, Williams J, Rigas B. The role of NSAIDs in the prevention of colon cancer (NSAID in the prevention of colon cancer). Cancer Invest2002; 20: 1002-11)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-inflammatory compounds and uses thereof
  • Anti-inflammatory compounds and uses thereof
  • Anti-inflammatory compounds and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0153] Embodiment 1. synthetic method

[0154] The present compound 5 (p-aspirin phosphate) shown below was obtained according to the following reaction scheme. Compound 5 was synthesized from o-acetylsalicyloyl chloride (1) and 4-hydroxybenzaldehyde (2) in three steps as shown below.

[0155]

[0156] In this scheme, -OEt represents CH 3 CH 2 O-.

[0157] Step 1: Preparation of compound 3: 4-Hydroxybenzaldehyde (2, 1.04 g, 8.49 mmol) in dichloromethane (10 mL) and pyridine (4.16 mL, 50 moles) were pre-cooled (0 °C) solution was added dropwise o-acetyl salicyloyl chloride (1, 1.98 g, 10 mmol) prepared in dichloromethane (10 mL). The temperature of the reaction mixture was slowly raised to room temperature and left overnight. At this point, TLC of the reaction mixture showed the reaction was complete. Water (25mL), 1N HCl (25mL) and aqueous NaHCO 3 The reaction mixture was washed. The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated. ...

Embodiment 4

[0181] Embodiment 4. Compared with the parent compound, the antitumor ability of 6 kinds of NSAID-based novel compounds is significantly improved

[0182] According to Penning et al. (Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, etc., Synthesis and biological evaluation of the1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl) Synthesis and biological evaluation of 3-(trifluoromethyl)-1H-pyrazol-1-yl]benzonesulfonamide (SC-58635, celecoxib) (1,5-diarylpyrazol-like cyclooxygenase-2 inhibitors: 4 Identification of -[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, celecoxib).J Med Chem 1997; 40: 1347-65) and the method described here, based on 4 representative NSAIDs: aspirin (2 derivatives with different linkers), ibuprofen, flurbiprofen and sulindac (sulindac 2 derivatives with different acid moieties) to synthesize 6 compounds. Their structures and NMR patterns are sho...

Embodiment 5

[0199] Example 5: Phospho-sulindac I inhibits colon cancer growth in vivo

[0200] In two animal models of colon cancer (APC Min / + The effect of phospho-sulindac I on tumor growth was assessed in colon cancer xenografts in mice and nude mice).

[0201] APCs Min / + Mouse studies: Min mice have a truncating mutation in the Apc gene that predisposes them to develop gastrointestinal tumors in the small intestine and colon (Lipkin M, Yang K, Edelmann W et al, Preclinical mouse models for cancer chemoprevention studies (Cancer Preclinical mouse models for chemoprevention studies). Ann N Y Acad Sci 1999;889:14-9). This model system represents a useful (and widely used) experimental system for describing colon cancer-related steps in many important ways.

[0202] 11-week-old male C57BL / 6J APC Min / + Mice were divided into 4 groups of 10 and treated by gavage for 4 weeks as follows: Group 1 was treated with vehicle (corn oil); Group 2 was treated with phospho-sulindac I at 50 mg / kg / d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compounds of the general formula are disclosed with activity towards treating diseases related to inflammation, such as cancer, neurodegenerative and cardiovascular diseases. Pharmaceutical compositions and methods of use are also disclosed.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application Serial No. 60 / 955,258, filed August 10, 2007, and US Provisional Application Serial No. 60 / 989,584, filed November 21, 2007. The contents of both provisional applications are incorporated herein by reference in their entirety. field of invention [0003] The present invention relates to compounds and pharmaceutical compositions for treating inflammation-related diseases, especially cancer. Background of the invention [0004] Inflammation is a key part of the immune system, which plays a role in defense and pathophysiological events to maintain the homeostasis of tissues, organs and individual cells. Inflammation can be classified as acute or chronic. Acute inflammation is a short-term process characterized by the classic signs of inflammation, namely swelling, redness, pain, heat, and loss of function due to plasma and leukemic infiltrated tissue. It is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F9/09A61K31/19A01N37/10A61P25/28A61P35/02A61P19/02
CPCC07F9/091C07F9/094C07F9/093C07F9/65742A61P1/04A61P11/00A61P11/02A61P11/08A61P13/08A61P19/02A61P19/04A61P25/00A61P25/28A61P27/02A61P29/00A61P35/00A61P35/02A61P37/00A61P37/02A61P37/06A61P43/00A61P9/00A61P9/10A61P9/12A61P9/14A61K31/661A61K31/6615
Inventor 巴赛尔·雷盖斯
Owner 巴赛尔·雷盖斯